George P Kent, MD
Family Practice · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 15
- 3 carriers
- Offices
- 2
Offices
2 locations · University Healthcare Alliance · County of Santa Clara
Looking this up.
Hospitals listed: El Camino Health · Good Samaritan Hospital · Santa Clara Valley Medical Center · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
15 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Kent’s office at (408) 995-5453 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
15 of 15 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G46421 · Current
Licensed to practise in California · since 1981 · expires 2027-06-30 · Case Western Reserve University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$41,782
Medicare paid this office $41,782 for 148 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $6,744 | $105 |
| Short return visit (20+ min) | 54 | $6,535 | $77 |
| Return visit (30+ min) | 30 | $5,481 | $112 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 34 | $5,205 | $153 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $3,410 | $148 |
See all 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $6,744 | $105 |
| Short return visit (20+ min) | 54 | $6,535 | $77 |
| Return visit (30+ min) | 30 | $5,481 | $112 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 34 | $5,205 | $153 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $3,410 | $148 |
| Return visit (30+ min) | 18 | $2,454 | $65 |
| Hospital discharge day management, 30 minutes or less | 21 | $1,485 | $71 |
| Influenza vaccine split virus, preservative free | 11 | $900 | $82 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 29 | $717 | $15 |
| Administration of influenza virus vaccine | 12 | $459 | $38 |
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
| Skin biopsy | 1-10 | None |
Who their Medicare patients are
148 Original Medicare patients in 2024. Average age 74 · Under 65 12% · 85 and older 12% · Women 42% · Also on Medicaid 32% · Health risk score 1.79. Above the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 72% · Diabetes 39% · Coronary heart disease 30% · Chronic kidney disease 25% · Atrial fibrillation 24% · Depression 23% · Heart failure 21% · COPD 15% · Cancer 13% · Dementia 10% · Stroke 10%.
The office billed $176,745, Medicare allowed $53,715 and paid $41,782; for 545 services of 41 kinds; $4,896 of it was for drugs given in the office and $36,886 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 148 | 545 | 74 | 1.79 | $176,745 | $41,782 |
| 2023 | 163 | 392 | 74 | 1.82 | $159,008 | $37,762 |
| 2022 | 135 | 374 | 74 | 1.62 | $148,694 | $36,029 |
| 2021 | 124 | 317 | 72 | 1.90 | $133,452 | $30,288 |
| 2020 | 147 | 366 | 72 | 1.74 | $142,290 | $29,834 |
| 2019 | 163 | 627 | 73 | 1.99 | $196,553 | $40,833 |
| 2018 | 175 | 467 | 72 | 2.16 | $169,376 | $36,156 |
| 2017 | 159 | 465 | 72 | 2.26 | $147,916 | $36,342 |
| 2016 | 125 | 368 | 73 | 2.19 | $114,819 | $31,310 |
| 2015 | 159 | 461 | 72 | 1.86 | $118,317 | $36,433 |
| 2014 | 167 | 390 | 74 | 1.90 | $109,750 | $35,903 |
| 2013 | 218 | 514 | 73 | 2.04 | $94,602 | $46,026 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 41 | $8,668 | $104 |
| Return visit (30+ min) | 35 | $5,244 | $105 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 33 | $5,196 | $157 |
| Short return visit (20+ min) | 41 | $4,250 | $69 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 24 | $3,742 | $156 |
| Hospital discharge day management, 30 minutes or less | 34 | $2,522 | $74 |
| Return visit (30+ min) | 11 | $1,412 | $74 |
2022: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 28 | $6,072 | $93 |
| Return visit (30+ min) | 38 | $6,010 | $104 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $4,555 | $182 |
| Short return visit (20+ min) | 38 | $3,502 | $71 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 22 | $3,481 | $158 |
| Hospital discharge day management, 30 minutes or less | 22 | $1,619 | $67 |
| Long return visit (40+ min) | 11 | $1,591 | $106 |
| Return visit (30+ min) | 11 | $1,344 | $71 |
| Influenza vaccine split virus, preservative free | 12 | $822 | $69 |
| Administration of influenza virus vaccine | 14 | $521 | $37 |
2021: 8 services
| Return visit (30+ min) | 35 | $5,424 | $106 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 27 | $4,733 | $93 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 22 | $3,600 | $164 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $3,345 | $186 |
| Short return visit (20+ min) | 26 | $2,563 | $75 |
| Hospital discharge day management, 30 minutes or less | 22 | $1,501 | $68 |
| Influenza vaccine split virus, preservative free | 12 | $783 | $65 |
| Administration of influenza virus vaccine | 14 | $307 | $22 |
2020: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 33 | $6,316 | $97 |
| Return visit (30+ min) | 34 | $3,916 | $83 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,631 | $188 |
| Short return visit (20+ min) | 25 | $1,956 | $63 |
| Hospital discharge day management, 30 minutes or less | 27 | $1,863 | $69 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 12 | $1,727 | $144 |
| Telephone medical discussion with physician, 11-20 minutes | 15 | $1,301 | $65 |
| Return visit (30+ min) | 11 | $1,110 | $55 |
| Administration of influenza virus vaccine | 15 | $314 | $21 |
2019: 10 services
| Return visit (30+ min) | 51 | $7,885 | $88 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 36 | $6,251 | $95 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 21 | $4,054 | $184 |
| Short return visit (20+ min) | 39 | $3,264 | $53 |
| Long return visit (40+ min) | 12 | $2,433 | $81 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,790 | $66 |
| Hospital discharge day management, 30 minutes or less | 22 | $1,492 | $68 |
| Influenza vaccine split virus, preservative free | 19 | $1,148 | $55 |
| Administration of influenza virus vaccine | 21 | $472 | $21 |
| Administration of pneumococcal vaccine | 11 | $226 | $21 |
2018: 12 services
| Return visit (30+ min) | 44 | $6,633 | $87 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 31 | $4,350 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $3,592 | $180 |
| Short return visit (20+ min) | 41 | $3,571 | $56 |
| Long return visit (40+ min) | 14 | $2,535 | $127 |
| Long return visit (40+ min) | 14 | $1,995 | $74 |
| Hospital discharge day management, 30 minutes or less | 25 | $1,650 | $66 |
| Return visit (30+ min) | 12 | $1,272 | $61 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $915 | $65 |
| Influenza vaccine split virus, preservative free | 15 | $780 | $52 |
| Administration of influenza virus vaccine | 18 | $463 | $26 |
| Administration of pneumococcal vaccine | 14 | $360 | $26 |
2017: 12 services
| Return visit (30+ min) | 38 | $5,767 | $84 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $5,032 | $180 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $3,876 | $90 |
| Short return visit (20+ min) | 29 | $2,918 | $60 |
| Long return visit (40+ min) | 11 | $2,707 | $135 |
| Hospital discharge day management, 30 minutes or less | 34 | $2,093 | $62 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 13 | $1,801 | $139 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $1,490 | $57 |
| Pneumococcal vaccine, 23-valent | 12 | $1,136 | $95 |
| Influenza vaccine split virus, preservative free | 17 | $859 | $48 |
| Administration of influenza virus vaccine | 19 | $646 | $32 |
| Administration of pneumococcal vaccine | 19 | $614 | $32 |
2016: 12 services
| Return visit (30+ min) | 29 | $5,064 | $84 |
| Long return visit (40+ min) | 15 | $3,562 | $111 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $3,245 | $180 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 22 | $3,070 | $85 |
| Pneumococcal vaccine, 13-valent | 14 | $2,461 | $176 |
| Initial hospital care with same-day admission and discharge with high level of medical decision making, per day at least 85 minutes | 12 | $2,246 | $187 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 14 | $1,927 | $138 |
| Short return visit (20+ min) | 25 | $1,846 | $56 |
| Hospital discharge day management, 30 minutes or less | 28 | $1,841 | $66 |
| Influenza vaccine split virus, preservative free | 20 | $806 | $40 |
| Administration of influenza virus vaccine | 20 | $634 | $32 |
| Administration of pneumococcal vaccine | 16 | $507 | $32 |
2015: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 44 | $6,750 | $95 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 31 | $5,718 | $179 |
| Return visit (30+ min) | 29 | $4,819 | $88 |
| Short return visit (20+ min) | 33 | $3,313 | $60 |
| Hospital discharge day management, 30 minutes or less | 47 | $3,259 | $68 |
| Pneumococcal vaccine, 13-valent | 15 | $2,508 | $167 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,532 | $67 |
| Administration of influenza virus vaccine | 21 | $668 | $32 |
| Administration of pneumococcal vaccine | 15 | $476 | $32 |
2014: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 53 | $9,956 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 40 | $7,842 | $178 |
| Initial hospital care with same-day admission and discharge with high level of medical decision making, per day at least 85 minutes | 25 | $4,452 | $178 |
| Return visit (30+ min) | 24 | $3,716 | $84 |
| Hospital discharge day management, 30 minutes or less | 44 | $2,945 | $64 |
| Short return visit (20+ min) | 29 | $1,883 | $55 |
| Administration of influenza virus vaccine | 12 | $405 | $31 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | 12 | $153 | $12 |
2013: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 86 | $16,669 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 50 | $8,556 | $171 |
| Initial hospital care with same-day admission and discharge with high level of medical decision making, per day at least 85 minutes | 24 | $4,477 | $187 |
| Hospital discharge day management, 30 minutes or less | 67 | $4,377 | $64 |
| Return visit (30+ min) | 30 | $3,472 | $81 |
| Short return visit (20+ min) | 35 | $2,879 | $59 |
| Long return visit (40+ min) | 14 | $1,891 | $118 |
| Administration of influenza virus vaccine | 11 | $353 | $32 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | 11 | $130 | $12 |
Medicaid work
$104,438 in 2024
Medicaid paid $104,438 for 926 billed services this clinician did in 2024, up to 62 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 392 | $98,450 |
| Short return visit (20+ min) | 392 | $3,907 |
| Return visit (30+ min) | 83 | $1,762 |
| Short return visit | 30 | $169 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 12 | $150 |
| Medication list documented in medical record (COA) | 17 | $0 |
| 2024 | 926 | 6 | 62 | $104,438 |
| 2023 | 1,557 | 7 | 69 | $146,647 |
| 2022 | 1,251 | 5 | 60 | $117,053 |
| 2021 | 5,093 | 20 | 246 | $423,874 |
| 2020 | 6,657 | 20 | 243 | $492,188 |
| 2019 | 5,567 | 25 | 182 | $409,164 |
| 2018 | 4,959 | 20 | 274 | $595,392 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 577 | $139,821 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 180 | $3,233 |
| Short return visit (20+ min) | 572 | $1,601 |
| 1ST HOSP IP/OBS HIGH 75 | 42 | $985 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 30 | $441 |
| Return visit (30+ min) | 136 | $436 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 20 | $130 |
2022
| Clinic visit/encounter, all-inclusive | 481 | $111,906 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 135 | $3,446 |
| Short return visit (20+ min) | 594 | $1,419 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 12 | $188 |
| Short return visit | 29 | $93 |
2021
| Clinic visit/encounter, all-inclusive | 1,735 | $408,269 |
| Short return visit (20+ min) | 1,255 | $3,647 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 89 | $1,954 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 97 | $1,851 |
| Pure tone audiometry (threshold); air only | 238 | $1,841 |
| Short return visit | 689 | $1,602 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 98 | $1,538 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 24 | $1,244 |
| Return visit (30+ min) | 99 | $397 |
| 1ST HOSP IP/OBS HIGH 75 | 14 | $312 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 18 | $211 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 55 | $204 |
2020
| Clinic visit/encounter, all-inclusive | 2,078 | $474,208 |
| Short return visit (20+ min) | 1,668 | $4,846 |
| Pure tone audiometry (threshold); air only | 347 | $2,573 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 85 | $2,379 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 325 | $1,798 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 73 | $1,629 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 57 | $1,058 |
| Short return visit | 550 | $1,045 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 203 | $709 |
| Hemoglobin A1C level | 84 | $363 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 78 | $357 |
| HEMOGLOBIN | 565 | $336 |
2019
| Clinic visit/encounter, all-inclusive | 1,674 | $380,187 |
| Short return visit (20+ min) | 1,147 | $4,335 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 105 | $3,339 |
| Hepatitis B vaccine (HepB), adult dosage, 3 dose schedule, for intramuscular use | 47 | $3,107 |
| Pure tone audiometry (threshold); air only | 269 | $2,707 |
| Human Papillomavirus vaccine, types 6, 11, 16, 18, quadrivalent (4vHPV), 3 dose schedule, for intramuscular use | 70 | $2,596 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 362 | $2,249 |
| Return visit (30+ min) | 124 | $1,526 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 276 | $1,521 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 87 | $1,366 |
| Short return visit | 279 | $962 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 32 | $914 |
2018
| Clinic visit/encounter, all-inclusive | 2,185 | $489,686 |
| Short return visit (20+ min) | 819 | $35,986 |
| Return visit (30+ min) | 521 | $31,744 |
| Hepatitis B vaccine (HepB), adult dosage, 3 dose schedule, for intramuscular use | 114 | $9,857 |
| Human Papillomavirus vaccine, types 6, 11, 16, 18, quadrivalent (4vHPV), 3 dose schedule, for intramuscular use | 125 | $5,385 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 38 | $4,562 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 38 | $4,435 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 122 | $3,749 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 152 | $2,578 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 273 | $2,376 |
| Pure tone audiometry (threshold); air only | 143 | $1,929 |
| Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular use | 40 | $1,444 |
Drugs they prescribed that Part D paid
$1,074,140
Pharmacies billed $1,074,140 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (22 of 2,100) in 2024. At or below the middle of the specialty; the typical family practice clinician is at 2%.
1,547 generic and 538 brand-name prescriptions · $1,074,140 in drug cost · 21 antibiotic prescriptions to 18 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Biktarvy | 117 | $463,992 | $3,966 |
| Triumeq | 63 | $209,549 | $3,326 |
| Juluca | 29 | $101,073 | $3,485 |
| Dovato | 23 | $61,519 | $2,675 |
| Odefsey | 12 | $37,920 | $3,160 |
See all 53 drugs
| Biktarvy | 117 | $463,992 | $3,966 |
| Triumeq | 63 | $209,549 | $3,326 |
| Juluca | 29 | $101,073 | $3,485 |
| Dovato | 23 | $61,519 | $2,675 |
| Odefsey | 12 | $37,920 | $3,160 |
| Tivicay | 12 | $30,654 | $2,554 |
| Jardiance | 39 | $29,798 | $764 |
| Synjardy Xr | 17 | $14,937 | $879 |
| Ozempic | 17 | $14,585 | $858 |
| Myrbetriq | 28 | $11,688 | $417 |
| Tradjenta | 14 | $6,931 | $495 |
| Arnuity Ellipta | 12 | $4,538 | $378 |
| Pitavastatin | 16 | $1,991 | $124 |
| Rosuvastatin | 112 | $1,297 | $12 |
| Trospium Chloride | 24 | $1,072 | $45 |
| Atorvastatin | 131 | $855 | $7 |
| Amlodipine-Olmesartan | 13 | $719 | $55 |
| Gabapentin | 55 | $712 | $13 |
| Levothyroxine | 79 | $664 | $8 |
| Eszopiclone | 11 | $644 | $59 |
| Lactated Ringers | 11 | $644 | $59 |
| Hydrocodone-Acetaminophen | 22 | $626 | $28 |
| Ultra-Fine Short Pen Needle | 11 | $583 | $53 |
| Flunisolide | 12 | $543 | $45 |
| Tamsulosin | 71 | $541 | $8 |
| Amlodipine Besylate | 87 | $409 | $5 |
| Fenofibrate | 13 | $397 | $31 |
| Humulin 70-30 | 11 | $380 | $35 |
| Losartan | 60 | $372 | $6 |
| Levetiracetam | 18 | $310 | $17 |
| Metoprolol | 38 | $285 | $7 |
| Loperamide | 16 | $281 | $18 |
| Valacyclovir | 15 | $277 | $18 |
| Metformin Hcl Er | 41 | $251 | $6 |
| Emtricitabine-Tenofovir Disop | 13 | $213 | $16 |
| Bupropion Hcl Sr | 20 | $201 | $10 |
| Losartan-Hydrochlorothiazide | 13 | $171 | $13 |
| Omeprazole | 17 | $171 | $10 |
| Lisinopril | 29 | $163 | $6 |
| Lisinopril-Hydrochlorothiazide | 19 | $159 | $8 |
| Amlodipine Besylate-Benazepril | 16 | $148 | $9 |
| Latanoprost | 12 | $140 | $12 |
| Lorazepam | 23 | $137 | $6 |
| Bupropion Xl | 15 | $128 | $9 |
| Minoxidil | 15 | $120 | $8 |
| Finasteride | 13 | $119 | $9 |
| Benazepril | 23 | $114 | $5 |
| Propranolol | 11 | $103 | $9 |
| Hydrochlorothiazide | 20 | $92 | $5 |
| Metformin | 22 | $63 | $3 |
| Furosemide | 16 | $46 | $3 |
| Sertraline | 18 | $43 | $2 |
| Diazepam | 14 | $35 | $3 |
Year by year
| 2024 | 2,100 | 142 | 1% (22) | 26% | $1,074,140 |
| 2023 | 2,022 | 138 | None | 28% | $1,111,815 |
| 2022 | 1,860 | 133 | 1% (16) | 27% | $1,012,460 |
| 2021 | 1,777 | 151 | 2% (33) | 24% | $809,777 |
| 2020 | 1,919 | 177 | 2% (37) | None | $844,690 |
| 2019 | 1,836 | 147 | 3% (53) | None | $707,750 |
| 2018 | 1,730 | 147 | 3% (59) | 21% | $526,260 |
| 2017 | 1,642 | 113 | 3% (53) | None | $416,063 |
| 2016 | 1,758 | 117 | 3% (56) | None | $525,849 |
| 2015 | 1,856 | 117 | 4% (69) | None | $458,694 |
| 2014 | 1,775 | 139 | 3% (60) | None | $372,850 |
| 2013 | 2,072 | 205 | 3% (70) | 27% | $276,269 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 59 drugs
| Biktarvy | 103 | $414,056 | $4,020 |
| Triumeq | 49 | $182,997 | $3,735 |
| Juluca | 31 | $111,416 | $3,594 |
| Odefsey | 14 | $53,681 | $3,834 |
| Dovato | 14 | $49,887 | $3,563 |
| Tivicay | 13 | $29,604 | $2,277 |
| Jardiance | 32 | $29,278 | $915 |
| Descovy | 12 | $27,690 | $2,307 |
| Ozempic | 11 | $12,705 | $1,155 |
| Xigduo Xr | 12 | $7,414 | $618 |
| Synjardy Xr | 12 | $7,273 | $606 |
| Tradjenta | 12 | $6,928 | $577 |
| Lantus Solostar | 17 | $5,034 | $296 |
| Arnuity Ellipta | 14 | $4,265 | $305 |
| Livalo | 12 | $3,925 | $327 |
| Tolterodine Tartrate Er | 16 | $2,848 | $178 |
| Rosuvastatin | 79 | $2,707 | $34 |
| Humulin 70-30 | 15 | $2,421 | $161 |
| Ursodiol | 11 | $1,993 | $181 |
| Trospium Chloride Er | 11 | $1,636 | $149 |
| Estradiol | 17 | $1,505 | $89 |
| Emtricitabine-Tenofovir Disop | 16 | $1,459 | $91 |
| Lactated Ringers | 22 | $1,366 | $62 |
| Atorvastatin | 129 | $1,302 | $10 |
| Trospium Chloride | 27 | $1,273 | $47 |
| Albuterol Sulfate Hfa | 18 | $1,166 | $65 |
| Amlodipine Besylate | 117 | $1,031 | $9 |
| Flunisolide | 18 | $916 | $51 |
| Losartan | 82 | $888 | $11 |
| Levothyroxine | 57 | $869 | $15 |
| Memantine | 11 | $662 | $60 |
| Ritonavir | 13 | $588 | $45 |
| Tamsulosin | 45 | $550 | $12 |
| Amlodipine Besylate-Benazepril | 16 | $406 | $25 |
| Losartan-Hydrochlorothiazide | 15 | $395 | $26 |
| Metformin | 32 | $392 | $12 |
| Bupropion Xl | 16 | $388 | $24 |
| Gabapentin | 32 | $387 | $12 |
| Loperamide | 17 | $328 | $19 |
| Imiquimod | 13 | $299 | $23 |
| Metformin Hcl Er | 35 | $292 | $8 |
| Trazodone | 11 | $288 | $26 |
| Benazepril | 39 | $252 | $6 |
| Metoprolol | 30 | $249 | $8 |
| Lisinopril | 37 | $245 | $7 |
| Pantoprazole | 11 | $178 | $16 |
| Finasteride | 13 | $178 | $14 |
| Sertraline | 24 | $171 | $7 |
| Hydralazine | 17 | $152 | $9 |
| Omeprazole | 12 | $145 | $12 |
| Carvedilol | 17 | $142 | $8 |
| Lisinopril-Hydrochlorothiazide | 14 | $133 | $10 |
| Eszopiclone | 12 | $133 | $11 |
| Hydrochlorothiazide | 16 | $111 | $7 |
| Fluticasone Propionate | 14 | $91 | $7 |
| Diazepam | 14 | $53 | $4 |
| Famotidine | 18 | $46 | $3 |
| Furosemide | 11 | $40 | $4 |
| Lorazepam | 12 | $31 | $3 |
2022: 54 drugs
| Biktarvy | 107 | $404,576 | $3,781 |
| Triumeq | 48 | $168,520 | $3,511 |
| Juluca | 35 | $118,297 | $3,380 |
| Symtuza | 13 | $60,020 | $4,617 |
| Odefsey | 12 | $42,041 | $3,503 |
| Dovato | 14 | $25,462 | $1,819 |
| Prezista | 12 | $22,777 | $1,898 |
| Jardiance | 18 | $19,483 | $1,082 |
| Isentress Hd | 11 | $19,459 | $1,769 |
| Xigduo Xr | 13 | $7,706 | $593 |
| Lantus Solostar | 27 | $7,434 | $275 |
| Livalo | 13 | $4,489 | $345 |
| Testosterone | 14 | $3,405 | $243 |
| Rosuvastatin | 61 | $2,388 | $39 |
| Trospium Chloride | 27 | $2,351 | $87 |
| Arnuity Ellipta | 13 | $2,335 | $180 |
| Humulin 70-30 | 14 | $2,228 | $159 |
| Estradiol | 13 | $1,317 | $101 |
| Flunisolide | 23 | $1,308 | $57 |
| Atorvastatin | 110 | $1,288 | $12 |
| Ritonavir | 18 | $1,064 | $59 |
| Losartan | 76 | $822 | $11 |
| Gabapentin | 36 | $763 | $21 |
| Amlodipine Besylate | 91 | $762 | $8 |
| Levothyroxine | 31 | $699 | $23 |
| Bupropion Xl | 20 | $659 | $33 |
| Albuterol Sulfate Hfa | 18 | $629 | $35 |
| Duloxetine | 11 | $596 | $54 |
| Metformin Hcl Er | 19 | $490 | $26 |
| Finasteride | 22 | $433 | $20 |
| Emtricitabine-Tenofovir Disop | 11 | $399 | $36 |
| Imiquimod | 13 | $345 | $27 |
| Sertraline | 50 | $315 | $6 |
| Escitalopram | 16 | $268 | $17 |
| Fluocinonide | 13 | $252 | $19 |
| Benazepril | 35 | $245 | $7 |
| Metoprolol | 12 | $236 | $20 |
| Eszopiclone | 11 | $217 | $20 |
| Tamsulosin | 24 | $215 | $9 |
| Amlodipine Besylate-Benazepril | 14 | $203 | $15 |
| Levetiracetam | 11 | $201 | $18 |
| Carvedilol | 21 | $191 | $9 |
| Metoprolol | 20 | $190 | $10 |
| Metformin | 29 | $158 | $5 |
| Alendronate | 12 | $147 | $12 |
| Hydrochlorothiazide | 17 | $128 | $8 |
| Lisinopril | 34 | $126 | $4 |
| Lisinopril-Hydrochlorothiazide | 12 | $124 | $10 |
| Simvastatin | 20 | $113 | $6 |
| Medroxyprogesterone Acetate | 12 | $104 | $9 |
| Hydralazine | 11 | $75 | $7 |
| Trazodone | 13 | $65 | $5 |
| Diazepam | 14 | $53 | $4 |
| Ibuprofen | 11 | $30 | $3 |
2021: 48 drugs
| Biktarvy | 94 | $323,134 | $3,438 |
| Triumeq | 47 | $153,175 | $3,259 |
| Juluca | 38 | $114,197 | $3,005 |
| Symtuza | 13 | $49,481 | $3,806 |
| Odefsey | 11 | $33,343 | $3,031 |
| Prezista | 12 | $21,426 | $1,785 |
| Xigduo Xr | 13 | $6,530 | $502 |
| Lantus Solostar | 14 | $4,378 | $313 |
| Livalo | 13 | $3,929 | $302 |
| Flovent Hfa | 12 | $3,374 | $281 |
| Testosterone | 14 | $2,415 | $173 |
| Arnuity Ellipta | 12 | $2,052 | $171 |
| Humulin 70-30 | 12 | $1,909 | $159 |
| Atorvastatin | 134 | $1,725 | $13 |
| Rosuvastatin | 58 | $1,689 | $29 |
| Flunisolide | 23 | $1,357 | $59 |
| Levothyroxine | 46 | $1,075 | $23 |
| Trospium Chloride | 13 | $931 | $72 |
| Losartan | 81 | $904 | $11 |
| Gabapentin | 47 | $881 | $19 |
| Amlodipine Besylate | 103 | $864 | $8 |
| Albuterol Sulfate Hfa | 15 | $827 | $55 |
| Levetiracetam | 16 | $792 | $49 |
| Ritonavir | 12 | $688 | $57 |
| Bupropion Xl | 17 | $617 | $36 |
| Finasteride | 20 | $453 | $23 |
| Metformin Hcl Er | 18 | $382 | $21 |
| Escitalopram | 17 | $381 | $22 |
| Imiquimod | 13 | $362 | $28 |
| Sertraline | 34 | $303 | $9 |
| Lisinopril | 28 | $298 | $11 |
| Benazepril | 29 | $283 | $10 |
| Oxybutynin Chloride Er | 19 | $262 | $14 |
| Fluocinonide | 12 | $238 | $20 |
| Triamcinolone Acetonide | 11 | $233 | $21 |
| Hydrocodone-Acetaminophen | 16 | $231 | $14 |
| Tamsulosin | 19 | $219 | $12 |
| Hydrochlorothiazide | 30 | $183 | $6 |
| Omeprazole | 21 | $177 | $8 |
| Metoprolol | 18 | $161 | $9 |
| Trazodone | 16 | $102 | $6 |
| Zolpidem | 18 | $96 | $5 |
| Metformin | 20 | $87 | $4 |
| Fluticasone Propionate | 12 | $65 | $5 |
| Tramadol | 11 | $64 | $6 |
| Furosemide | 13 | $56 | $4 |
| Warfarin | 11 | $52 | $5 |
| Ibuprofen | 15 | $46 | $3 |
2020: 54 drugs
| Biktarvy | 121 | $386,412 | $3,193 |
| Juluca | 43 | $120,841 | $2,810 |
| Triumeq | 32 | $98,794 | $3,087 |
| Symtuza | 14 | $51,005 | $3,643 |
| Prezista | 19 | $32,581 | $1,715 |
| Jardiance | 13 | $12,560 | $966 |
| Livalo | 14 | $4,109 | $293 |
| Testosterone | 12 | $3,166 | $264 |
| Arnuity Ellipta | 13 | $2,159 | $166 |
| Shingrix | 12 | $2,039 | $170 |
| Humulin 70-30 | 12 | $1,913 | $159 |
| Atorvastatin | 145 | $1,859 | $13 |
| Levothyroxine | 56 | $1,329 | $24 |
| Albuterol Sulfate Hfa | 17 | $1,181 | $69 |
| Flunisolide | 19 | $1,142 | $60 |
| Amlodipine Besylate | 92 | $983 | $11 |
| Losartan | 66 | $861 | $13 |
| Rosuvastatin | 33 | $852 | $26 |
| Imiquimod | 14 | $757 | $54 |
| Bupropion Xl | 14 | $718 | $51 |
| Finasteride | 22 | $716 | $33 |
| Ritonavir | 11 | $630 | $57 |
| Benazepril-Hydrochlorothiazide | 22 | $622 | $28 |
| Levetiracetam | 18 | $554 | $31 |
| Oxybutynin Chloride Er | 19 | $430 | $23 |
| Metoprolol | 28 | $408 | $15 |
| Gabapentin | 35 | $340 | $10 |
| Sertraline | 38 | $336 | $9 |
| Fluocinonide | 15 | $334 | $22 |
| Metformin Hcl Er | 38 | $305 | $8 |
| Benazepril | 26 | $279 | $11 |
| Tamsulosin | 34 | $271 | $8 |
| Triamcinolone Acetonide | 15 | $245 | $16 |
| Hydrocodone-Acetaminophen | 20 | $237 | $12 |
| Hydrochlorothiazide | 41 | $233 | $6 |
| Metformin | 27 | $215 | $8 |
| Metoprolol | 22 | $194 | $9 |
| Escitalopram | 15 | $193 | $13 |
| Digoxin | 13 | $167 | $13 |
| Lisinopril | 32 | $164 | $5 |
| Omeprazole | 14 | $164 | $12 |
| Fosinopril | 16 | $156 | $10 |
| Fluticasone Propionate | 15 | $155 | $10 |
| Oxybutynin Chloride | 12 | $135 | $11 |
| Trazodone | 16 | $92 | $6 |
| Alprazolam | 18 | $86 | $5 |
| Zolpidem | 13 | $85 | $7 |
| Warfarin | 13 | $84 | $6 |
| Tramadol | 17 | $78 | $5 |
| Ibuprofen | 18 | $78 | $4 |
| Furosemide | 18 | $76 | $4 |
| Lorazepam | 15 | $68 | $5 |
| Diazepam | 12 | $52 | $4 |
| Glipizide | 17 | $50 | $3 |
2019: 53 drugs
| Biktarvy | 98 | $297,102 | $3,032 |
| Triumeq | 31 | $89,488 | $2,887 |
| Juluca | 32 | $83,693 | $2,615 |
| Symtuza | 12 | $41,966 | $3,497 |
| Prezista | 17 | $27,791 | $1,635 |
| Flovent Hfa | 13 | $3,446 | $265 |
| Atorvastatin | 137 | $1,826 | $13 |
| Ritonavir | 16 | $1,474 | $92 |
| Levothyroxine | 54 | $1,281 | $24 |
| Ventolin Hfa | 21 | $1,181 | $56 |
| Benazepril-Hydrochlorothiazide | 20 | $980 | $49 |
| Nifedipine Er | 24 | $951 | $40 |
| Flunisolide | 16 | $885 | $55 |
| Losartan | 65 | $786 | $12 |
| Finasteride | 26 | $723 | $28 |
| Fenofibrate | 11 | $712 | $65 |
| Amlodipine Besylate | 74 | $610 | $8 |
| Oxybutynin Chloride Er | 16 | $548 | $34 |
| Rosuvastatin | 15 | $508 | $34 |
| Albuterol Sulfate Hfa | 12 | $495 | $41 |
| Hydrocodone-Acetaminophen | 34 | $485 | $14 |
| Doxazosin Mesylate | 19 | $467 | $25 |
| Valacyclovir | 12 | $347 | $29 |
| Gabapentin | 27 | $339 | $13 |
| Oxybutynin Chloride | 17 | $334 | $20 |
| Pravastatin | 15 | $329 | $22 |
| Levetiracetam | 17 | $320 | $19 |
| Ranitidine | 15 | $318 | $21 |
| Digoxin | 11 | $316 | $29 |
| Metoprolol | 16 | $279 | $17 |
| Fluocinonide | 14 | $272 | $19 |
| Metformin | 18 | $249 | $14 |
| Losartan-Hydrochlorothiazide | 12 | $233 | $19 |
| Sertraline | 33 | $221 | $7 |
| Metformin Hcl Er | 25 | $212 | $8 |
| Hydrochlorothiazide | 43 | $197 | $5 |
| Benazepril | 26 | $193 | $7 |
| Omeprazole | 16 | $192 | $12 |
| Tamsulosin | 16 | $187 | $12 |
| Escitalopram | 15 | $159 | $11 |
| Fosinopril | 12 | $157 | $13 |
| Metoprolol | 16 | $151 | $9 |
| Lorazepam | 37 | $150 | $4 |
| Lisinopril | 29 | $143 | $5 |
| Alprazolam | 22 | $133 | $6 |
| Hydroxyzine | 13 | $127 | $10 |
| Trazodone | 23 | $120 | $5 |
| Triamcinolone Acetonide | 11 | $119 | $11 |
| Warfarin | 19 | $102 | $5 |
| Zolpidem | 14 | $88 | $6 |
| Tramadol | 12 | $81 | $7 |
| Furosemide | 21 | $68 | $3 |
| Ibuprofen | 11 | $48 | $4 |
2018: 44 drugs
| Triumeq | 53 | $145,185 | $2,739 |
| Biktarvy | 22 | $64,030 | $2,910 |
| Tivicay | 33 | $53,427 | $1,619 |
| Descovy | 28 | $47,137 | $1,683 |
| Genvoya | 15 | $43,597 | $2,906 |
| Prezista | 21 | $32,237 | $1,535 |
| Lyrica | 11 | $9,989 | $908 |
| Ritonavir | 15 | $2,585 | $172 |
| Abacavir-Lamivudine | 13 | $2,301 | $177 |
| Atorvastatin | 127 | $1,744 | $14 |
| Fenofibrate | 25 | $1,123 | $45 |
| Levothyroxine | 46 | $1,012 | $22 |
| Flunisolide | 14 | $713 | $51 |
| Amlodipine Besylate | 85 | $660 | $8 |
| Nifedipine Er | 23 | $650 | $28 |
| Finasteride | 27 | $648 | $24 |
| Oxybutynin Chloride | 21 | $633 | $30 |
| Doxazosin Mesylate | 19 | $609 | $32 |
| Hydrocodone-Acetaminophen | 37 | $550 | $15 |
| Gabapentin | 34 | $500 | $15 |
| Losartan | 46 | $476 | $10 |
| Fluticasone Propionate | 14 | $274 | $20 |
| Metformin | 31 | $251 | $8 |
| Metoprolol | 18 | $250 | $14 |
| Tamsulosin | 24 | $250 | $10 |
| Benazepril | 29 | $192 | $7 |
| Hydrochlorothiazide | 42 | $192 | $5 |
| Omeprazole | 21 | $188 | $9 |
| Lisinopril | 45 | $186 | $4 |
| Lorazepam | 35 | $168 | $5 |
| Levetiracetam | 11 | $155 | $14 |
| Metoprolol | 23 | $153 | $7 |
| Lisinopril-Hydrochlorothiazide | 15 | $153 | $10 |
| Carbidopa-Levodopa | 12 | $140 | $12 |
| Sertraline | 23 | $138 | $6 |
| Alprazolam | 20 | $132 | $7 |
| Atenolol | 26 | $113 | $4 |
| Zolpidem | 16 | $101 | $6 |
| Fosinopril | 12 | $97 | $8 |
| Triamcinolone Acetonide | 12 | $90 | $8 |
| Glipizide | 28 | $90 | $3 |
| Pantoprazole | 15 | $59 | $4 |
| Furosemide | 20 | $45 | $2 |
| Bisoprolol-Hydrochlorothiazide | 16 | $22 | $1 |
2017: 43 drugs
| Triumeq | 56 | $142,112 | $2,538 |
| Descovy | 35 | $54,959 | $1,570 |
| Genvoya | 20 | $52,666 | $2,633 |
| Tivicay | 28 | $42,760 | $1,527 |
| Prezista | 24 | $34,303 | $1,429 |
| Abacavir-Lamivudine | 22 | $7,640 | $347 |
| Norvir | 20 | $5,168 | $258 |
| Flovent Hfa | 11 | $2,578 | $234 |
| Atorvastatin | 117 | $1,320 | $11 |
| Levothyroxine | 62 | $1,255 | $20 |
| Metformin Hcl Er | 13 | $1,024 | $79 |
| Amlodipine Besylate | 91 | $753 | $8 |
| Doxazosin Mesylate | 21 | $635 | $30 |
| Fenofibrate | 18 | $612 | $34 |
| Nifedipine Er | 17 | $605 | $36 |
| Pravastatin | 14 | $515 | $37 |
| Gabapentin | 38 | $490 | $13 |
| Losartan | 54 | $450 | $8 |
| Hydrocodone-Acetaminophen | 37 | $381 | $10 |
| Finasteride | 21 | $377 | $18 |
| Tamsulosin | 26 | $319 | $12 |
| Omeprazole | 25 | $314 | $13 |
| Pantoprazole | 16 | $237 | $15 |
| Eszopiclone | 15 | $227 | $15 |
| Clopidogrel | 12 | $222 | $19 |
| Metformin | 32 | $222 | $7 |
| Hydrochlorothiazide | 50 | $219 | $4 |
| Lovastatin | 20 | $218 | $11 |
| Benazepril | 28 | $197 | $7 |
| Lisinopril-Hydrochlorothiazide | 19 | $183 | $10 |
| Loperamide | 15 | $183 | $12 |
| Lorazepam | 36 | $168 | $5 |
| Metoprolol | 13 | $167 | $13 |
| Lisinopril | 46 | $164 | $4 |
| Carbidopa-Levodopa | 12 | $152 | $13 |
| Metoprolol | 38 | $140 | $4 |
| Levetiracetam | 11 | $129 | $12 |
| Trazodone | 17 | $122 | $7 |
| Sertraline | 26 | $105 | $4 |
| Glipizide | 25 | $90 | $4 |
| Atenolol | 23 | $47 | $2 |
| Alprazolam | 16 | $35 | $2 |
| Furosemide | 12 | $18 | $1 |
2016: 51 drugs
| Triumeq | 34 | $80,088 | $2,356 |
| Genvoya | 25 | $64,577 | $2,583 |
| Prezista | 35 | $47,049 | $1,344 |
| Truvada | 25 | $37,245 | $1,490 |
| Reyataz | 18 | $24,983 | $1,388 |
| Descovy | 15 | $22,391 | $1,493 |
| Tivicay | 14 | $19,830 | $1,416 |
| Epzicom | 15 | $19,351 | $1,290 |
| Selzentry | 12 | $15,575 | $1,298 |
| Intelence | 11 | $12,003 | $1,091 |
| Norvir | 42 | $11,890 | $283 |
| Abacavir | 17 | $5,584 | $328 |
| Metformin Hcl Er | 13 | $4,046 | $311 |
| Lamivudine | 25 | $2,928 | $117 |
| Fenofibrate | 18 | $1,402 | $78 |
| Atorvastatin | 106 | $1,344 | $13 |
| Levothyroxine | 42 | $856 | $20 |
| Gabapentin | 30 | $735 | $25 |
| Proair Hfa | 18 | $728 | $40 |
| Fluocinonide | 13 | $699 | $54 |
| Pravastatin | 22 | $641 | $29 |
| Oxybutynin Chloride Er | 12 | $626 | $52 |
| Doxazosin Mesylate | 18 | $605 | $34 |
| Ventolin Hfa | 11 | $579 | $53 |
| Hydrocodone-Acetaminophen | 31 | $522 | $17 |
| Losartan | 53 | $478 | $9 |
| Amlodipine Besylate | 61 | $444 | $7 |
| Metoprolol | 26 | $369 | $14 |
| Nifedipine Er | 20 | $337 | $17 |
| Famotidine | 13 | $317 | $24 |
| Afeditab Cr | 15 | $314 | $21 |
| Omeprazole | 30 | $312 | $10 |
| Memantine | 11 | $290 | $26 |
| Hydrochlorothiazide | 34 | $220 | $6 |
| Metformin | 32 | $212 | $7 |
| Benazepril | 47 | $212 | $5 |
| Finasteride | 20 | $183 | $9 |
| Lisinopril-Hydrochlorothiazide | 21 | $179 | $9 |
| Lovastatin | 22 | $148 | $7 |
| Lorazepam | 30 | $133 | $4 |
| Sertraline | 33 | $132 | $4 |
| Lisinopril | 37 | $129 | $3 |
| Trazodone | 23 | $127 | $6 |
| Fosinopril | 11 | $123 | $11 |
| Losartan-Hydrochlorothiazide | 11 | $111 | $10 |
| Metoprolol | 32 | $110 | $3 |
| Glipizide Xl | 11 | $102 | $9 |
| Alprazolam | 24 | $99 | $4 |
| Glipizide | 28 | $86 | $3 |
| Atenolol | 29 | $62 | $2 |
| Furosemide | 11 | $28 | $3 |
2015: 58 drugs
| Truvada | 70 | $95,295 | $1,361 |
| Reyataz | 50 | $63,996 | $1,280 |
| Prezista | 45 | $51,648 | $1,148 |
| Triumeq | 16 | $34,846 | $2,178 |
| Epzicom | 25 | $29,549 | $1,182 |
| Norvir | 93 | $25,176 | $271 |
| Tivicay | 15 | $19,784 | $1,319 |
| Intelence | 19 | $15,587 | $820 |
| Kaletra | 12 | $10,585 | $882 |
| Selzentry | 11 | $9,565 | $870 |
| Edurant | 11 | $9,372 | $852 |
| Abacavir | 21 | $6,285 | $299 |
| Namenda | 24 | $5,032 | $210 |
| Morphine Sulfate Er | 20 | $3,187 | $159 |
| Lamivudine | 24 | $3,105 | $129 |
| Metformin Hcl Er | 24 | $2,466 | $103 |
| Atorvastatin | 88 | $1,403 | $16 |
| Fenofibrate | 19 | $1,355 | $71 |
| Gabapentin | 38 | $1,098 | $29 |
| Bupropion | 11 | $983 | $89 |
| Pravastatin | 32 | $968 | $30 |
| Levothyroxine | 30 | $869 | $29 |
| Doxazosin Mesylate | 19 | $809 | $43 |
| Hydrocodone-Acetaminophen | 29 | $616 | $21 |
| Losartan | 53 | $583 | $11 |
| Metoprolol | 18 | $494 | $27 |
| Proair Hfa | 14 | $489 | $35 |
| Diphenoxylate-Atropine | 15 | $450 | $30 |
| Omeprazole | 47 | $367 | $8 |
| Oxybutynin Chloride | 13 | $297 | $23 |
| Nifedipine Er | 19 | $285 | $15 |
| Benazepril | 52 | $272 | $5 |
| Hydrochlorothiazide | 38 | $271 | $7 |
| Quetiapine | 12 | $257 | $21 |
| Fluticasone Propionate | 11 | $209 | $19 |
| Amlodipine Besylate | 41 | $197 | $5 |
| Lisinopril-Hydrochlorothiazide | 22 | $179 | $8 |
| Donepezil | 21 | $177 | $8 |
| Lisinopril | 41 | $176 | $4 |
| Metformin | 22 | $174 | $8 |
| Fosinopril | 15 | $161 | $11 |
| Lorazepam | 33 | $155 | $5 |
| Montelukast | 11 | $149 | $14 |
| Finasteride | 14 | $149 | $11 |
| Famotidine | 11 | $145 | $13 |
| Lovastatin | 25 | $142 | $6 |
| Carbidopa-Levodopa | 11 | $140 | $13 |
| Simvastatin | 14 | $128 | $9 |
| Metoprolol | 28 | $126 | $4 |
| Levetiracetam | 12 | $121 | $10 |
| Atenolol | 27 | $104 | $4 |
| Sertraline | 29 | $100 | $3 |
| Trazodone | 12 | $86 | $7 |
| Alprazolam | 24 | $82 | $3 |
| Glipizide | 18 | $80 | $4 |
| Clonidine | 13 | $40 | $3 |
| Citalopram Hbr | 11 | $33 | $3 |
| Diazepam | 11 | $14 | $1 |
2014: 51 drugs
| Reyataz | 47 | $63,345 | $1,348 |
| Truvada | 48 | $62,171 | $1,295 |
| Prezista | 32 | $33,674 | $1,052 |
| Norvir | 78 | $21,172 | $271 |
| Epzicom | 11 | $18,584 | $1,689 |
| Adcirca | 11 | $17,426 | $1,584 |
| Isentress | 15 | $14,219 | $948 |
| Kaletra | 11 | $8,922 | $811 |
| Namenda | 23 | $7,023 | $305 |
| Abacavir | 19 | $5,862 | $309 |
| Morphine Sulfate Er | 15 | $2,811 | $187 |
| Qvar | 13 | $2,356 | $181 |
| Actonel | 11 | $2,245 | $204 |
| Metformin Hcl Er | 13 | $2,031 | $156 |
| Avodart | 14 | $2,009 | $144 |
| Atorvastatin | 78 | $1,896 | $24 |
| Pravastatin | 61 | $1,675 | $27 |
| Lovaza | 12 | $1,413 | $118 |
| Vivelle-Dot | 11 | $950 | $86 |
| Gabapentin | 46 | $837 | $18 |
| Levothyroxine | 29 | $750 | $26 |
| Nifedipine Er | 27 | $706 | $26 |
| Nitrofurantoin Mono-Macro | 11 | $673 | $61 |
| Metoprolol | 18 | $671 | $37 |
| Losartan | 43 | $594 | $14 |
| Fenofibrate | 13 | $513 | $39 |
| Donepezil | 35 | $474 | $14 |
| Benazepril | 59 | $436 | $7 |
| Omeprazole | 55 | $426 | $8 |
| Hydrocodone-Acetaminophen | 39 | $399 | $10 |
| Diphenoxylate-Atropine | 15 | $358 | $24 |
| Carbidopa-Levodopa | 12 | $328 | $27 |
| Amlodipine Besylate | 55 | $321 | $6 |
| Quetiapine | 12 | $303 | $25 |
| Metformin | 17 | $213 | $13 |
| Lovastatin | 20 | $213 | $11 |
| Lisinopril | 41 | $208 | $5 |
| Simvastatin | 16 | $198 | $12 |
| Hydrochlorothiazide | 34 | $197 | $6 |
| Lorazepam | 34 | $189 | $6 |
| Sertraline | 31 | $183 | $6 |
| Carvedilol | 13 | $169 | $13 |
| Lisinopril-Hydrochlorothiazide | 19 | $157 | $8 |
| Famotidine | 14 | $129 | $9 |
| Fosinopril | 12 | $120 | $10 |
| Atenolol | 29 | $112 | $4 |
| Triamcinolone Acetonide | 11 | $95 | $9 |
| Alprazolam | 21 | $95 | $5 |
| Clonidine | 11 | $82 | $7 |
| Trazodone | 11 | $81 | $7 |
| Metoprolol | 11 | $47 | $4 |
2013: 51 drugs
| Truvada | 46 | $54,340 | $1,181 |
| Reyataz | 43 | $45,414 | $1,056 |
| Isentress | 15 | $14,600 | $973 |
| Norvir | 38 | $9,643 | $254 |
| Namenda | 25 | $6,766 | $271 |
| Cymbalta | 17 | $6,329 | $372 |
| Lantus | 11 | $2,830 | $257 |
| Qvar | 15 | $2,439 | $163 |
| Atorvastatin | 63 | $2,412 | $38 |
| Metformin Hcl Er | 11 | $2,300 | $209 |
| Morphine Sulfate Er | 11 | $1,817 | $165 |
| Actonel | 12 | $1,700 | $142 |
| Pravastatin | 74 | $1,355 | $18 |
| Montelukast | 11 | $1,276 | $116 |
| Gabapentin | 37 | $1,122 | $30 |
| Vivelle-Dot | 14 | $1,042 | $74 |
| Nasonex | 11 | $1,041 | $95 |
| Omeprazole | 90 | $964 | $11 |
| Nitrofurantoin Mono-Macro | 14 | $883 | $63 |
| Promethazine | 11 | $840 | $76 |
| Donepezil | 38 | $816 | $21 |
| Losartan | 37 | $790 | $21 |
| Nifedipine Er | 19 | $706 | $37 |
| Amlodipine Besylate | 87 | $648 | $7 |
| Benazepril | 67 | $641 | $10 |
| Levothyroxine | 49 | $595 | $12 |
| Lisinopril | 80 | $497 | $6 |
| Benazepril-Hydrochlorothiazide | 12 | $488 | $41 |
| Tamsulosin | 20 | $424 | $21 |
| Metformin | 42 | $421 | $10 |
| Venlafaxine Hcl Er | 17 | $421 | $25 |
| Alendronate | 30 | $400 | $13 |
| Carbidopa-Levodopa | 16 | $393 | $25 |
| Doxazosin Mesylate | 27 | $366 | $14 |
| Hydrocodone-Acetaminophen | 27 | $317 | $12 |
| Carvedilol | 23 | $310 | $13 |
| Lovastatin | 25 | $292 | $12 |
| Hydrochlorothiazide | 60 | $283 | $5 |
| Quetiapine | 11 | $277 | $25 |
| Metoprolol | 28 | $256 | $9 |
| Simvastatin | 29 | $253 | $9 |
| Ibuprofen | 35 | $252 | $7 |
| Atenolol | 45 | $246 | $5 |
| Sertraline | 33 | $227 | $7 |
| Clonidine | 19 | $171 | $9 |
| Lorazepam | 21 | $111 | $5 |
| Terazosin | 12 | $104 | $9 |
| Glyburide | 11 | $99 | $9 |
| Furosemide | 20 | $98 | $5 |
| Warfarin | 14 | $92 | $7 |
| Alprazolam | 18 | $80 | $4 |
Money from drug and device companies
$17 in 2024
A payment is not proof that care is biased.
| Pfizer | Myfembree | $17 | 1 payment
|
See the published payment
| Pfizer | Education · 2024-05-09 | Myfembree | $17 |
Professional record
- NPI
- 1861456246
- Licence
- CA G46421California G46421: Current · expires 2027-06-30
- Trained
- Clvlnd Clinic Lerner College of Med of Case Wstn Rsv University, 1980
- Group
- University Healthcare Alliance · County of Santa Clara
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G464210
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 455 Oconnor Dr, Suite 210, San Jose, CA, 95128
- NPI first listed
- 2006-04-13
- NPI last updated
- 2012-02-02
This is when the NPI record was last certified, not a medical board exam.